Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other
companies in this sector in the United States:
sales of $13.30 million
of which 77%
was Bronchitol and Aridol),
Nascent Biotech Inc
Aytu Bioscience Inc
Sales increased substantially in 2017:
During the year ended June of 2017, sales at
Clinuvel Pharmaceuticals Limited were $12.84 million.
increase of 151.3%
versus 2016, when the company's sales were $5.11 million.
This was the third consecutive year of growth at Clinuvel Pharmaceuticals Limited.